4 Results for "

L929 normal cells

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "L929 normal cells" in MCE Product Catalog:

Cat. No.: HY-W109224
CAS No.: 4265-59-2
Research Areas:  

Cancer

3,3'-(Propane-2,2-diylbis (sulfanediyl)) dipropionic acid is a ROS-sensitive cleavable linker. 3,3'-(Propane-2,2-diylbis (sulfanediyl)) dipropionic acid is stable under physiological conditions, but undergoes cleavage in the ROS-rich tumor microenvironment, enabling the release of conjugated Camptothecin (CPT) (HY-16560). 3,3'-(Propane-2,2-diylbis (sulfanediyl)) dipropionic acid can be used in the research of cervical cancer .
loading...
    loading...
Cat. No.: HY-183789
Target:  

CDK Apoptosis

Research Areas:  

Cancer

CDK2-IN-59 is a CDK2 inhibitor with a IC50 of 66.33 μM. CDK2-IN-59 stably interacts within the CDK2 active site and induces apoptosis in breast cancer cells. CDK2-IN-59 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-183670
CAS No.: 3038340-43-8
Target:  

JAK STAT Apoptosis

Research Areas:  

Infection Cancer

JAK2-IN-21 is a Janus kinase 2 (JAK2) inhibitor with an IC50 of 12.25 nM. JAK2-IN-21 inhibits the JAK2/STAT3/STAT5 tumor-promoting signaling pathway and reduces JAK2 protein expression. JAK2-IN-21 exhibits selective cytotoxicity against HPV-positive cancer cells and induces cancer cell apoptosis. JAK2-IN-21 can be used in the research of HPV-positive cervical cancer .
loading...
    loading...
Cat. No.: HY-189464
Target:  

EGFR Akt STAT Apoptosis

Research Areas:  

Cancer

EGFR/Akt/STAT3-IN-1 is an EGFR/Akt/STAT3 inhibitor (IC50 values of 9.79 μM, 17.80 μM, and 8.30 μM, respectively) that induces apoptosis and G0/G1 cell cycle arrest by inhibiting EGFR tyrosine kinase, Akt kinase, and STAT3 transcriptional activity, and exhibits selective cytotoxicity against cancer cells. EGFR/Akt/STAT3-IN-1 can be used for research on non-small cell lung cancer .
loading...
    loading...